Erlotinib Completed Phase 1 Trials for Advanced Cancers / Tumors, Solid Treatment
Indications | Status | Purpose | Phase |
---|---|---|---|
Completed | Treatment | 1 |
clinicaltrials.gov Identifier | Title | Drugs |
---|---|---|
NCT00895362 | Erlotinib in Combination With Cetuximab | |
NCT00903734 | An Umbrella, Modular Study Based on Epidermal Growth Factor Receptor (EGFR) Mutation Status | |
NCT01532011 | Erlotinib in Combination With Pralatrexate in Advanced Malignancies | |
NCT01009073 | A Study Evaluating ABT-263 With Erlotinib, ABT-263 With Irinotecan, and ABT-263 Monotherapy in Cancer Subjects | |
NCT00495872 | Valproic Acid-Based 2-Agent Oral Regimens for Patients With Advanced Solid Tumor | |
NCT00770263 | Erlotinib and Temsirolimus for Solid Tumors |